The bladder cancer market is poised for transformative growth between 2025 and 2035, driven by rising global incidence rates, ...

In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...

Merck can create deep learning models that will help scientists understand whether or not to pursue a certain drug structure ... cancer immunotherapy Keytruda. Data from clinical trials are ...

In addition, efti in combination with KEYTRUDA continues to be well-tolerated with no ... The work by Monash University and Immutep, is also the first to show the crystal structure of a human ...

Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

In Oncology, we and our partner Merck have multiple late-stage studies underway evaluating INT or mRNA-4157 in combination with KEYTRUDA ... to adjust our cost structure to ensure we breakeven ...

So when you look at the nature of that, particularly for the stop loss books, its drugs like Keytruda or Ocrevus ... undertake significant work to structure their benefits in a deliberate way ...

Media Release Marking Immutep’s transition to a Phase III biotech, the Company’s pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature ...

Only a few days prior, Sanofi also stated that it would simplify its R&D structure, but noted only ... Johnson & Johnson (Stelara), and Merck (Keytruda), among others. This need for capital ...

ALPENA — Home is more than a physical structure — it’s a place where ... “Dr. Hitzelberger said the medication Keytruda had to be tried as it was my best shot. My cancer was advanced ...